GalNAc-T8 is a member of the polypeptide N-acetylgalactosaminyltransferase enzyme family, often shortened to GalNAc-transferases. These enzymes are pivotal in the process of mucin-type O-linked glycosylation, a biochemical modification where a sugar molecule, specifically N-acetylgalactosamine (GalNAc), is added to the hydroxyl groups of serine or threonine residues on proteins. This post-translational modification is crucial for the proper function of many proteins, influencing their stability, localization, and interactions with other molecules. The expression of GalNAc-T8 is a highly regulated process within the cell, as it is with other enzymes in the glycosylation pathway. The regulation is often multifaceted, with different biological factors and intracellular signaling pathways interacting to control the levels of this enzyme.
A variety of chemical compounds have been identified as potential activators that could induce the expression of GalNAc-T8, although these compounds may act through various mechanisms. Compounds like retinoic acid and beta-estradiol can bind to specific nuclear receptors, potentially initiating transcriptional events that lead to the upregulation of enzymes including GalNAc-T8. Other compounds, such as 5-Azacytidine or Trichostatin A, act epigenetically to remove molecular brakes that silence genes, thereby enabling the activation of gene expression. Forskolin, by increasing intracellular cAMP levels, can activate a cascade that culminates in the transcription of certain genes. Cellular stressors or response modifiers like Tunicamycin might trigger compensatory cellular mechanisms that could include the upregulation of GalNAc-T8 as part of a broader response to maintain cellular homeostasis. On the other hand, compounds like Mithramycin A interfere with specific DNA-binding proteins, altering the transcriptional activity of genes, which may include glycosyltransferases like GalNAc-T8. It is important to note that while these compounds have been identified as potential activators, the direct induction of GalNAc-T8 expression by these chemicals would require detailed experimental studies to verify their exact mechanisms and effects.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could upregulate GalNAc-T8 expression by binding to retinoic acid receptors, which leads to the transcriptional activation of genes involved in glycosylation processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As an inhibitor of DNA methyltransferases, 5-Azacytidine may elicit the expression of GalNAc-T8 by promoting the hypomethylation of DNA and reactivating silenced gene promoters. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin might stimulate GalNAc-T8 expression by elevating intracellular cAMP, which in turn activates CREB, a transcription factor that can initiate transcription of glycosylation-related genes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA could trigger an increase in GalNAc-T8 levels by activating protein kinase C, which plays a role in signal transduction pathways that could promote the transcription of glycosyltransferase genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin may stimulate the expression of GalNAc-T8 by altering the activity of transcription factors and DNA methyltransferases, thereby changing gene expression profiles related to glycosylation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could induce the transcription of GalNAc-T8 by inhibiting histone deacetylases, leading to a more accessible chromatin structure and enhanced transcription of certain genes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol may upregulate GalNAc-T8 through estrogen receptor-mediated transcriptional activation, potentially initiating the expression of genes encoding glycosylation enzymes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could augment GalNAc-T8 gene expression by activating glucocorticoid receptors, which bind to glucocorticoid response elements on DNA and stimulate gene transcription. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin may induce an upsurge in GalNAc-T8 expression as a cellular response to inhibited N-linked glycosylation, potentially enhancing the O-linked glycosylation pathway as a compensatory mechanism. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride might stimulate the synthesis of GalNAc-T8 by inhibiting GSK-3 activity, thereby altering downstream signaling pathways that control the expression of glycosylation-related genes. | ||||||